The APS is pleased to announce an affiliation with the journals Pharmaceutics, Pharmaceuticals and Pharmacy and publication of the biopharmaceutics focus group meeting report on clinically relevant specifications – available as open access on MDPI Pharmaceutics:

Meeting Report: Developing Clinically Relevant Dissolution Specifications for Oral Drug Products—Industrial and Regulatory Perspectives
Mark McAllister, Talia Flanagan, Karin Boon, Xavier Pepin, Christophe Tistaert, Masoud Jamei, Andreas Abend, Evangelos Kotzagiorgis and Claire Mackie

Pharmaceutics 2020, 12(1), 19; doi:10.3390/pharmaceutics12010019

Pharmaceutics (ISSN 1999-4923) is an open access journal which provides an advanced forum for the science and technology of pharmaceutics and biopharmaceutics. Covered topics include pharmaceutical formulation, process development, drug delivery, pharmacokinetics, biopharmaceutics, pharmacogenetics, and interdisciplinary research involving, but not limited to, engineering, biomedical sciences, and cell biology. Pharmaceutics is indexed by SCIE (IF 4.773, ranks 26/267 (Q1) in the category of Pharmacology & Pharmacy), PubMed and Scopus; it also is a member of DOAJ.

The benefits for APS members are as follows:
• Discount on the article processing charges to publish in journals Pharmaceutics and Pharmaceuticals, and a discount for publications in Pharmacy.
• Dedicated Special Issues related to APS conferences and Events.
• Discounted publication fees for open access books.